Status:
NOT_YET_RECRUITING
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
Lead Sponsor:
Medical University of South Carolina
Conditions:
Squamous Cell Carcinoma Head and Neck Cancer (HNSCC)
Margin Assessment
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
This study is for adult patients with head and neck cancer who are at risk of recurrence. The purpose of this study is to evaluate whether the use of Indocyanine Green (ICG) dye allows for better iden...
Eligibility Criteria
Inclusion
- Adults ≥18 years
- Squamous cell carcinoma of head and neck mucosal origin
- Good operative candidate
- Capable of giving informed consent
Exclusion
- Pregnant women
- Known allergy to iodides or shellfish
- Currently incarcerated individuals
Key Trial Info
Start Date :
February 16 2026
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT07149207
Start Date
February 16 2026
End Date
December 1 2026
Last Update
January 7 2026
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina Hollings Cancer Center
Charleston, South Carolina, United States, 29425